| Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices | Ethem Murat ARSAVA, Mehmet Akif TOPÇUOĞLU, Esen SAKA | 102–110 |
| Non-pharmacologic Approaches to Dysphagia in Patients with Multiple Sclerosis: A Systematic Review | Gülşah KESİK, Leyla ÖZDEMİR | 111–116 |
| Association between PSEN1 p.E318G Variant and APOE Polymorphism and Alzheimer Disease in Turkish Patients | Başar BİLGİÇ, Hakan GÜRVİT, Haşmet HANAĞASI, Gamze GÜVEN, Ebba LOHMANN, Nihan ERGİNEL ÜNALTUNA, Rukiye ASLAN, Çağla DÖNMEZ | 117–122 |
| Cerebral Vasomotor Reactivity in Medically Stabilized Patients with Takayasu’s Arteritis | Ethem Murat ARSAVA, Mehmet Akif TOPÇUOĞLU, Ömer KARADAĞ, Mehmet Yasir PEKTEZEL, Sahip ROVSHANOV, Ertuğrul Çağrı BÖLEK, Farid KHASİYEV | 123–127 |
| The Profile of a Neurology Clinic and Malnutrition Awareness | Aysun SOYSAL, Eda ÇOBAN | 128–132 |
| The Predictive Value of the Systemic Immune-inflammation Index as a New Prognostic Marker for Disability in Patients with Multiple Sclerosis | Nermin TANIK, Tülin AKTÜRK, Hikmet SAÇMACI | 133–139 |
| Changes in Optical Coherence Tomography Parameters in Patients with Unilateral Carotid Artery Stenosis | Eylem ÖZAYDIN GÖKSU, Burcu YÜKSEL, Berna DOĞAN, Ayşegül CENGİZ ÜNAL | 140–144 |
| How Does Entacapon Affect Homocysteine Levels? | Gönül AKDAĞ, Feriha ÖZER, Mithat BEDİR, Gülsün GÜL, Özlem ÇOKAR, Belgin PETEK BALCI | 145–150 |
| Diffusion-Weighted-Imaging Negative Stroke Syndromes | Ethem Murat ARSAVA, Mehmet Akif TOPÇUOĞLU, Mehmet Yasir PEKTEZEL, Kader KARLI OĞUZ, Rahşan GÖÇMEN | 151–157 |
| Screening of Cognitive Dysfunction Using the Montreal Cognitive Assessment Test and Evaluation of Neurologic Complications in Turkish Adults With Sickle Cell Anemia | Erdal KURTOĞLU, Nazan ŞİMŞEK ERDEM, Ramazan ERDEM, Gönül OKTAY | 158–163 |
| The Diagnostic and Prognostic Value of Magnetic Resonance Imaging for Evaluating Atypical Inflammatory Demyelinating Lesions | Erkan ACAR, Aysun SOYSAL, Zeynep ÖZDEMİR |